Gables Capital Management Inc. Bristol Myers Squibb CO Transaction History
Gables Capital Management Inc.
- $195 Million
- Q3 2024
A detailed history of Gables Capital Management Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gables Capital Management Inc. holds 8,559 shares of BMY stock, worth $464,924. This represents 0.23% of its overall portfolio holdings.
Number of Shares
8,559
Previous 8,684
1.44%
Holding current value
$464,924
Previous $360,000
22.78%
% of portfolio
0.23%
Previous 0.19%
Shares
14 transactions
Others Institutions Holding BMY
# of Institutions
2,449Shares Held
1.51BCall Options Held
29.7MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.62 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.97 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.05 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.21 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...